David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Make ElectroCore a Core Holding after an Outstanding Q2

By David Moadel, InvestorPlace Contributor

Rock-solid financial stats and a highly specific medical technology add up to a compelling argument in favor of ECOR stock.

NextEra Energy Is a Lifetime Investment but Don’t Wait Forever

By David Moadel, InvestorPlace Contributor

Not every investment has to bring quick, mind-blowing gains. Consider NEE stock as an intergenerational holding for safety and consistency.

Big Profits Come from Small Cars With Electrameccanica Vehicles Stock

By David Moadel, InvestorPlace Contributor

If you can see a future for unusual-looking electric vehicles with room for just the driver, you're an ideal candidate to own SOLO stock.

Chill Out and Collect Dividends with Exxon Mobil

By David Moadel, InvestorPlace Contributor

Exxon Mobil is shifting to cleaner energy sources. You can take a position in this while collecting dividend payments with Exxon Mobil stock.

It’s Risky, but Milestone Pharmaceuticals Holds Promise Among Tiny Biotechs

By David Moadel, InvestorPlace Contributor

When a biotech firm focuses its efforts on one disease and one drug, the stakes are high. Still, the payoff could be huge with MIST stock.

Laugh If You Want, but This Trash Deal Is a Coup for Nikola Stock

By David Moadel, InvestorPlace Contributor

Waste management and electric vehicles are both big business. What do you get when you combine the two? A great reason to own Nikola stock.

Marathon Patent Group Is a Decent but Imperfect Bitcoin Price Proxy

By David Moadel, InvestorPlace Contributor

Investors shouldn't even consider buying MARA stock unless they're bullish, or at least neutral, on the future price of Bitcoin.

For Fun and Profits, Take a Chance and Try Arcimoto

By David Moadel, InvestorPlace Contributor

Ready to take a chance on a truly unique electric vehicle company? Dare to try something different with a position in Arcimoto stock.

Hold Eli Lilly as Mobile Covid-19 Labs Address Critical Needs

By David Moadel, InvestorPlace Contributor

Some folks consider LLY stock a dull investment, but don't forget that Eli Lilly could play a pivotal role in the battle against Covid-19.

Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment

By David Moadel, InvestorPlace Contributor

Don't hesitate to buy ABT stock as vast quantities of Covid-19 test shipments indicate robust business for Abbott Laboratories.

Load More